12/20
01:49 pm
zbh
PitchBook Releases 2025 Outlooks Highlighting Key Investment Trends Across Private Markets [Yahoo! Finance]
Low
Report
PitchBook Releases 2025 Outlooks Highlighting Key Investment Trends Across Private Markets [Yahoo! Finance]
12/20
11:27 am
zbh
4 Large Cap MedTech Stocks to Keep Winning Streaks Alive in 2025 [Yahoo! Finance]
Low
Report
4 Large Cap MedTech Stocks to Keep Winning Streaks Alive in 2025 [Yahoo! Finance]
12/20
10:51 am
zbh
Balt secures €355 million to refinance its debt and accelerate its growth [Yahoo! Finance]
Low
Report
Balt secures €355 million to refinance its debt and accelerate its growth [Yahoo! Finance]
12/20
08:10 am
zbh
Aspargo Labs Appoints General Managers in Spain and Germany to Drive International Expansion [Yahoo! Finance]
Low
Report
Aspargo Labs Appoints General Managers in Spain and Germany to Drive International Expansion [Yahoo! Finance]
12/20
07:59 am
zbh
Lower Extremity Implants Market is Expected to Reach USD 18.43 Billion by 2034, at a CAGR of 2.8% during 2025–2034 | PMR [Yahoo! Finance]
Low
Report
Lower Extremity Implants Market is Expected to Reach USD 18.43 Billion by 2034, at a CAGR of 2.8% during 2025–2034 | PMR [Yahoo! Finance]
12/20
07:30 am
zbh
Zimmer Biomet to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Low
Report
Zimmer Biomet to Present at the 43rd Annual J.P. Morgan Healthcare Conference
12/19
08:22 am
zbh
Axoft to Begin Brain Implant Clinical Study, Marking the First Time Bio-Inspired Material is Authorized for Use in Humans [Yahoo! Finance]
Low
Report
Axoft to Begin Brain Implant Clinical Study, Marking the First Time Bio-Inspired Material is Authorized for Use in Humans [Yahoo! Finance]
12/19
08:07 am
zbh
Highwire Appoints Mike Steavenson as Executive Vice President of Enterprise Technology Practice, Elevates Jason Mayde to CTO [Yahoo! Finance]
Low
Report
Highwire Appoints Mike Steavenson as Executive Vice President of Enterprise Technology Practice, Elevates Jason Mayde to CTO [Yahoo! Finance]
12/18
10:44 am
zbh
Zimmer Biomet Holdings, Inc. (NYSE: ZBH) had its price target raised by analysts at Truist Financial Co. from $117.00 to $118.00. They now have a "hold" rating on the stock.
Low
Report
Zimmer Biomet Holdings, Inc. (NYSE: ZBH) had its price target raised by analysts at Truist Financial Co. from $117.00 to $118.00. They now have a "hold" rating on the stock.
12/18
09:22 am
zbh
Zimmer Biomet Holdings (NYSE:ZBH) shareholders have endured a 23% loss from investing in the stock five years ago [Yahoo! Finance]
Low
Report
Zimmer Biomet Holdings (NYSE:ZBH) shareholders have endured a 23% loss from investing in the stock five years ago [Yahoo! Finance]
12/18
09:13 am
zbh
NeoPredics Welcomes Todd Usen as Chairman of the Board [Yahoo! Finance]
Low
Report
NeoPredics Welcomes Todd Usen as Chairman of the Board [Yahoo! Finance]
12/18
07:00 am
zbh
Zimmer Biomet Announces Quarterly Dividend for Fourth Quarter of 2024
Low
Report
Zimmer Biomet Announces Quarterly Dividend for Fourth Quarter of 2024
12/18
06:17 am
zbh
HKSTP Bringing Largest Ever Delegation of Hong Kong Tech to CES 2025 Highlighting Latest Solutions to Global Challenges [Yahoo! Finance]
Low
Report
HKSTP Bringing Largest Ever Delegation of Hong Kong Tech to CES 2025 Highlighting Latest Solutions to Global Challenges [Yahoo! Finance]
12/18
06:13 am
zbh
Bridge to Life Acquires VitaSmart™ Hypothermic Oxygenated Machine Perfusion System from Medica S.p.A. [Yahoo! Finance]
Low
Report
Bridge to Life Acquires VitaSmart™ Hypothermic Oxygenated Machine Perfusion System from Medica S.p.A. [Yahoo! Finance]
12/17
01:12 pm
zbh
Disrupting Restaurant Finances: Geordy Murphy Reveals How Real-Time Data Delivers 40% More Profit
Low
Report
Disrupting Restaurant Finances: Geordy Murphy Reveals How Real-Time Data Delivers 40% More Profit
12/17
08:15 am
zbh
Zimmer Biomet Holdings, Inc. (NYSE: ZBH) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating. They now have a $128.00 price target on the stock, up previously from $125.00.
Low
Report
Zimmer Biomet Holdings, Inc. (NYSE: ZBH) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating. They now have a $128.00 price target on the stock, up previously from $125.00.
12/16
01:15 pm
zbh
Vaso Corporation CEO Reflects on a Year of Growth and Innovation in End-of-Year Letter Setting the Tone for a Promising 2025 [Yahoo! Finance]
Low
Report
Vaso Corporation CEO Reflects on a Year of Growth and Innovation in End-of-Year Letter Setting the Tone for a Promising 2025 [Yahoo! Finance]
12/16
09:17 am
zbh
ZBH Stock Might Rise Following FDA Nod for OsseoFit [Yahoo! Finance]
Low
Report
ZBH Stock Might Rise Following FDA Nod for OsseoFit [Yahoo! Finance]
12/16
06:24 am
zbh
Zimmer Biomet's total shoulder replacement system gains FDA 510(k) clearance [Yahoo! Finance]
Low
Report
Zimmer Biomet's total shoulder replacement system gains FDA 510(k) clearance [Yahoo! Finance]
12/13
11:55 am
zbh
ACTION Centers Collaborate with Johnson & Johnson MedTech to Secure FDA Labeling for Impella Support System in Pediatric Patients [Yahoo! Finance]
Low
Report
ACTION Centers Collaborate with Johnson & Johnson MedTech to Secure FDA Labeling for Impella Support System in Pediatric Patients [Yahoo! Finance]
12/13
10:04 am
zbh
SPR® Therapeutics Recognized as the Fastest Growing Private Company in Northeast Ohio as Part of the Crain's Fast 50 List [Yahoo! Finance]
Low
Report
SPR® Therapeutics Recognized as the Fastest Growing Private Company in Northeast Ohio as Part of the Crain's Fast 50 List [Yahoo! Finance]
12/13
08:19 am
zbh
Disrupting M&A Benchmarking: Dania Shaheen Gutterson on AI Redefining Investment Analytics at Bain [Yahoo! Finance]
Low
Report
Disrupting M&A Benchmarking: Dania Shaheen Gutterson on AI Redefining Investment Analytics at Bain [Yahoo! Finance]
12/13
08:15 am
zbh
Disrupting M&A Benchmarking: Dania Shaheen Gutterson on AI Redefining Investment Analytics at Bain
Low
Report
Disrupting M&A Benchmarking: Dania Shaheen Gutterson on AI Redefining Investment Analytics at Bain
12/13
07:30 am
zbh
Zimmer Biomet Receives FDA Clearance for OsseoFit™ Stemless Shoulder System for Total Shoulder Replacement
Low
Report
Zimmer Biomet Receives FDA Clearance for OsseoFit™ Stemless Shoulder System for Total Shoulder Replacement
12/13
12:13 am
zbh
One powerful way Toronto fuels the growth of its key industries [Globe and Mail, The (Toronto, Canada)]
Low
Report
One powerful way Toronto fuels the growth of its key industries [Globe and Mail, The (Toronto, Canada)]